Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

McAdoo

Showing results (291-300 of 294) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 294 results.
Biorxiv : the Preprint Server for Biology|July 9, 2020
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemicMaria Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, et al.
Kidney International Reports|December 18, 2023
Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA NephropathyFrederick W K Tam, James Tumlin, Jonathan Barratt, et al.
Cell Reports. Medicine|December 9, 2020
A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung InjuryMaria Kost-Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, et al.
Journal of the American Society of Nephrology : JASN|December 12, 2023
The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and TrialsSebastian Bate, Dominic McGovern, Francesca Costigliolo, et al.
Pageof 30

Showing results (291-300 of 294) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 294 results.
Biorxiv : the Preprint Server for Biology|July 9, 2020
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemicMaria Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, et al.
Kidney International Reports|December 18, 2023
Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA NephropathyFrederick W K Tam, James Tumlin, Jonathan Barratt, et al.
Cell Reports. Medicine|December 9, 2020
A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung InjuryMaria Kost-Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, et al.
Journal of the American Society of Nephrology : JASN|December 12, 2023
The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and TrialsSebastian Bate, Dominic McGovern, Francesca Costigliolo, et al.
Pageof 30